miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53

miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53

(1) Background: To examine miR-429-meditated DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 (DDX53) function in endometrial cancer (EC). (2) Methods: DDX53 and miR-429 levels were measured using quantitative real-time polymerase chain reaction and western blotting assays, cell invasion and migration usin...

Full description

Bibliographic Details
Main Authors: Kyung-Jun Lee, Nitya Singh, Michael Bizuneh, Nam-Hyeok Kim, Hyeong Su Kim, Youngmi Kim, Jae-Jun Lee, Jung Han Kim, Jiye Kim, Soo Young Jeong, Hye-Yon Cho, Sung Taek Park
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Journal of Personalized Medicine
Subjects:
endometrial cancer
DDX53
miR-429
anti-cancer drug-resistance
Online Access:https://www.mdpi.com/2075-4426/13/9/1302

Internet

https://www.mdpi.com/2075-4426/13/9/1302

Similar Items